March 31, 2026
Content View Test
Discover Funded Researchers
Sheri L. Holmen, PhD
Targeting FAK/MEK to Potentiate Immune Checkpoint Inhibition in Melanoma
Chirag Vasavda, MD, PhD
A Chemical Proteomics Campaign for Rare Melanomas
Marija Simic, PhD
Role of the Immune Microenvironment in Melanoma Bone Metastasis
Roberta Zappasodi, PhD
Improving Immunotherapy by Modulating PD-1hiFoxp3-CD4+ T Cells in Melanoma
Luiz Henrique Medeiros Geraldo, MD, PhD
Slit-Robo Inhibition to Overcome Immunotherapy Resistance in Melanoma
Eva Hernando, PhD
Targeting Myeloid Checkpoints For Brain Metastasis Treatment
Grant Fischer, MD, PhD
Defining Collagen-Epigenome Interactions to Reveal Melanoma Vulnerabilities
Nicholas Collins, PhD
Developing Therapies that Mimic Caloric Restriction for Melanoma Control
Goran Micevic, MD, PhD
Epigenetic Therapies to Enhance Checkpoint Inhibitor Efficacy in Melanoma
Nosakhare Paul Ilerhunmwuwa, MBBS
OPRM1 AND CD8+ T-CELL SPATIAL DISTRIBUTION IN ADVANCED CUTANEOUS MELANOMA
Praveen Chatani, MD
Non-invasive Assessment of Response to Neoadjuvant Therapy in cN+ Melanoma
Élise Di Lena M.D., C.M., FRCSC, PhD
Sex-Specific Mechanisms of Immune Evasion in Cutaneous Melanoma
Antonio Bechara Ghobril, MD
Vision Loss After Plaque Radiotherapy for Posterior Uveal Melanoma
Ian Charles Garbarine, MD
Reprogramming Melanoma Tumor Microenvironment by Intratumoral Flu Vaccine a
Surya Veerabagu, MD
Cutaneous Genital and Acral Melanoma Treatment Trends and Outcomes
Michelle Ferreira, MD
Uncovering longitudinal microbiome changes in ICI resistance and toxicity
Mathew Schnorenberg, MD, PhD
Reprogramming Tumor Macrophages to Relieve T-Cell Inhibition in Melanoma
Kelly Herremans, MD
Oral Health and Oral-Gut Microbiome Features of Immunotherapy Response
Elena Hawryluk, MD, PhD
Unveiling the Genetic Landscape of Pediatric Melanomas and Precursors
Geethanjali Annamalai
